Copyright
©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 101277
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.101277
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.101277
Table 2 Studies on the therapeutic potential of gut microbiota in the treatment of various diseases
Microbiota-based intervention | Disease treated | Observations | Ref. |
Bifidobacterium lactis and Lactobacillus rhamnosus | Colorectal cancer | Significant reduction in cancer proliferation and improved epithelial barrier function in patients under placebo-controlled trials | [135] |
Lactobacillus reuteri | Gastric cancer | Human adenocarcinoma epithelial cells of the gastric tissue (AGS) treated with test strain showed reduced proliferation in dose-dependent manner | [136] |
Lactobacillus casei and Lactobacillus paracasei | Cervical cancer | Upregulation of apoptotic genes such as BAX, caspase 3, caspase 8 and caspase 9, downregulation of BCl-2 gene observed in HeLa cells | [137] |
Fecal microbiota transplantation | Clostridium difficile infection | Full primary or secondary response was achieved in 7 patients, with no serious after-effects contrary to metronidazole-treated control group | [138] |
Faecal microbiota transplantation | Ulcerative colitis | [139] | |
Fecal microbiota transplant | Recurrent hepatic encephalopathy | Improved cognition and dysbiosis | [140] |
- Citation: Khan AS, Kamthan M, Ali A. Understanding the intricate interactions between microbiota and host. World J Exp Med 2025; 15(3): 101277
- URL: https://www.wjgnet.com/2220-315X/full/v15/i3/101277.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i3.101277